Description
Orlistat Capsules Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Orlistat Capsules (Taijili) |
| Generic Name | Orlistat |
| Synonyms | Tetrahydrolipstatin, Xenical (brand reference) |
| Formulation | Oral capsules |
| Strength | 60?mg per capsule |
| Pack Size | 20 capsules (10 capsules × 2 blisters) per box |
| Dosage Form | Capsule |
| CAS Number | 96829-58-2 |
| Approval Number | H20183303 (China NMPA) |
| Product Code | 86905001000182 |
| Manufacturer | Hunan Mingrui Pharmaceutical Co., Ltd. |
| Barcode | 6920945600698 |
| Storage | Store below 25?°C in a dry, cool place |
| Intended Use | For laboratory research only |
Orlistat Capsules Mechanism of Action
Orlistat inhibits gastric and pancreatic lipases, enzymes responsible for the breakdown of triglycerides in the intestine. By blocking fat digestion, it reduces fat absorption and facilitates excretion via feces. Commonly used in research models of obesity, lipid metabolism, and fat-soluble vitamin bioavailability.
Orlistat Capsules Research Applications & Pharmacology
Obesity-related metabolic models
Lipid absorption & GI physiology studies
Nutrient & drug bioavailability testing
Combination studies with dietary compounds
Pharmacokinetics: very low systemic absorption (<1%)
Safety Profile & Handling Guidelines
Observed Effects in Preclinical Research:
GI disturbances (steatorrhea, oily stools)
Reduced absorption of fat-soluble vitamins (A, D, E, K)
Liver enzyme fluctuation (in some animal models)
Lab Handling Instructions:
Use gloves and mask to avoid contact with powdered content
Avoid inhalation or ingestion
Store away from moisture and light
Dispose according to hazardous waste protocols
?? Research-Use Disclaimer
This product is intended strictly for laboratory research purposes only. It is not approved for human, veterinary, diagnostic, or therapeutic use. Misuse may result in serious legal and health consequences. Always follow laboratory safety protocols when handling.


Reviews
There are no reviews yet.